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LABORATORY INVESTIGATION
The use of artificial nerve guides can be an alterna-tive to autograft for the repair of peripheral nerve defects. However, the length of the gap to be bridged 
determines the success of axonal regeneration after tube 
repair of transected nerves. Axonal regeneration occurs 
within hollow tubes implanted in rat peripheral nerves if 
the gap is shorter than 10 mm, but not in longer gaps.27 
In a previous study of repair of long-gap peripheral nerve 
injury in the rat, we demonstrated that chitosan tubes may 
be a promising biomaterial for the treatment of critical 
peripheral nerve lesions.17 However, in contrast with auto-
graft, repair with chitosan tubes did not allow for effective 
nerve regeneration in all instances.
Tissue-engineered alternatives for the design of com-
plex artificial nerve guides aim to mimic the structural 
and molecular microenvironment of a natural nerve graft, 
resembling the original tissue structure, topographical de-
sign, and composition.6 For this purpose, prefilling hollow 
tubes with extracellular matrix (ECM) components25,38 
and addition of cells into these constructs has been dem-
onstrated to enhance axonal regeneration. Schwann cells 
(SCs) have been the most common choice to promote 
regeneration through neural conduits. However, mesen-
chymal stem cells (MSCs), especially those isolated from 
bone marrow or adipose tissue, have emerged as an im-
portant alternative due to their higher potential for clini-
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OBJECTIVE Artificial nerve guides are being developed to substitute for autograft repair after peripheral nerve injuries. 
However, the use of conduits is limited by the length of the gap that needs to be bridged, with the success of regenera-
tion highly compromised in long gaps. Addition of aligned proregenerative cells and extracellular matrix (ECM) compo-
nents inside the conduit can be a good strategy to achieve artificial grafts that recreate the natural environment offered 
by a nerve graft. The purpose of this study was to functionalize chitosan devices with different cell types to support 
regeneration in limiting gaps in the rat peripheral nerve.
METHODS The authors used chitosan devices combined with proteins of the ECM and cells in a rat model of sciatic 
nerve injury. Combinations of fibronectin and laminin with mesenchymal stem cells (MSCs) or Schwann cells (SCs) were 
aligned within tethered collagen-based gels, which were placed inside chitosan tubes that were then used to repair a 
critical-size gap of 15 mm in the rat sciatic nerve. Electrophysiology and algesimetry tests were performed to analyze 
functional recovery during the 4 months after injury and repair. Histological analysis was performed at the midlevel and 
distal level of the tubes to assess the number of regenerated myelinated fibers.
RESULTS Functional analysis demonstrated that SC-aligned scaffolds resulted in 100% regeneration success in a 15-
mm nerve defect in this rat model. In contrast, animals that underwent repair with MSC-aligned constructs had only 90% 
regeneration success, and those implanted with acellular bridges had only 75% regeneration success.
CONCLUSIONS These results indicate that the combination of chitosan conduits with ECM-enriched cellular gels rep-
resents a good alternative to the use of autografts for repairing long nerve gaps.
https://thejns.org/doi/abs/10.3171/2017.5.SPINE161100
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cal application.19,21,22 The therapeutic roles of SCs12,35 and 
MSCs6,14 have been studied previously with respect to the 
repair of peripheral nerve injuries. Their tissue repair ac-
tivity has been attributed to their capacity for cell replace-
ment, production of growth factors, ECM synthesis, and 
immune modulation.39
In addition, alignment of cellular and extracellular con-
stituents of the composite graft has been shown to provide 
guidance and facilitate axonal regrowth when incorporat-
ed within nerve conduits. The incorporation of guiding el-
ements, such as microchannels or nanofibers, and the pre-
alignment of ECM components to direct axonal regrowth 
have been used previously.7,38 More recently, engineered 
neural tissue, based on stabilized self-aligned cellular 
gels, has emerged as an alternative for guiding regrowing 
axons after peripheral nerve injuries.15 When combining 
cell therapy with scaffolds to further improve the capa-
bilities of neural guides, it is important to take into ac-
count the interactions between the grafted cells and the 
scaffolds within which these cells are embedded. The use 
of collagen-based scaffolds allows the further addition of 
other ECM molecules, such as laminin38 and fibronectin,8 
that promote axonal regeneration. It remains, however, 
challenging to dissect the cooperative influence of mul-
tiple ECM parameters on cell behavior34 when evaluating 
cellular scaffolds within conduits to repair nerve defects.
In the present work, we have compared the capability 
of nerve guides containing SCs or MSCs to support regen-
eration across a critical peripheral nerve defect of 15 mm 
in the adult rat sciatic nerve. The conduits were made of 
chitosan and prefilled with stabilized self-aligned cellular 
collagen Type I scaffolds enriched with either fibronectin 
or laminin and containing SCs or MSCs. Since the cells 
were allogenic, animals were treated with the immuno-
suppressant FK506 during the first 2 months to avoid im-
mune rejection of transplanted cells. By means of func-
tional and morphological methods we assessed the effects 
of these aligned cellular constructs to sustain regeneration 




Female Wistar Hannover rats (Janvier) were used in the 
experiment. The animals were housed in plastic cages and 
maintained under standard conditions with free access to 
water and food. The experimental procedures were ap-
proved by the ethics committee of the Universitat Autòno-
ma de Barcelona and followed the rules of the European 
Communities Council Directive.
Mesenchymal Stem Cell Culture
MSCs were obtained from 21-day-old Wistar Han-
nover rats (n = 4). Animals were euthanized with carbon 
dioxide. Under a dissecting microscope, tibias and femurs 
were collected, placed in cold phosphate-buffered saline 
(PBS), and epiphyses were removed. Diaphyses of tibias 
and femurs were flushed with PBS using a syringe, and 
the marrow was homogenized. The cell extract was fil-
tered in a 70-μm nylon mesh and recovered by centrifuga-
tion for 10 minutes at 230g. Collected cells were grown 
in a-MEM medium supplemented with L-glutamine (Life 
Technologies), 20% fetal bovine serum (FBS; Lonza), and 
penicillin-streptomycin (Life Technologies, 100×), and 
plated in 100-mm culture dishes (Iwaki, Asahi Techno-
glass) at a density of 5 × 106 cells/cm2. After 24 hours, the 
supernatant containing nonadherent cells was removed 
and fresh medium was added. When the cell culture was 
near confluence, the cells were detached and replated at 
5000 cells/cm2.
Schwann Cell Culture
Dissociated SCs were also prepared from 21-day-old 
Wistar Hannover rats (n = 4). Animals were euthanized 
with carbon dioxide. Under a dissecting microscope, sciat-
ic and median nerves were exposed, removed, and cleaned 
of connective tissue, then cut into small pieces that were 
dissociated in 10% collagenase (Invitrogen), 10% tryp-
sin (Life Technologies), and 10% DNase (Invitrogen) in 
Hanks solution (Invitrogen) for 30 minutes at 37°C. Then, 
the nerves were mechanically dissociated by carefully re-
suspending the cell solution with a pipette, and the enzyme 
action was stopped by adding DMEM. After centrifuga-
tion, cells were plated in 35-mm culture dishes (Greiner 
Bio-One), pretreated with 10 μl/ml poly-d-lysine (Sigma), 
in DMEM supplemented with 10% fetal calf serum (FCS) 
and penicillin/streptomycin, at a density of 1 × 106 cells/
cm2. After 24 hours, the supernatant was removed and 
fresh medium was added. When the cell culture was near 
confluence, the cells were detached and replated at a den-
sity of 1000 cells/cm2.
Cell Survival and Proliferation Assays
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetra-
zo lium bromide; Sigma) was used to evaluate mitochon-
drial activity as an indirect measure of cell survival. 
Approximately 8000 MSCs and SCs were cultured on 
24-well plates previously treated with poly-d-lysine 10 
μl/ml, laminin (5 μg/cm2), or fibronectin (5 μg/cm2) for 
72 hours. Then, 0.15 mg/ml of MTT was added and the 
cells were incubated for 45 minutes at 37°C. The forma-
zan crystals were dissolved in 200 μl of dimethyl sulf-
oxide (DMSO) and 100 μl was passed to 96-well plates. 
The optimal density was determined with a microculture 
plate reader (BioTek Instruments) at 570 and 620 nm and 
analyzed with KCjunior software.
To analyze cell proliferation, MSCs and SCs were cul-
tured on glass coverslips pretreated with poly-d-lysine 10 
μl/ml, laminin (5 μg/cm2), or fibronectin (5 μg/cm2) for 
48 hours at 8000 cells per coverslip; 1 μl of BrdU was 
added to the cultures at 20 μM. One day later, the cells 
were fixed with 4% paraformaldehyde in PBS for 30 min-
utes and then treated with HCl at 2 M for 20 minutes at 
37°C. Afterward, the pH was re-equilibrated with Tris-
buffered saline (TBS) to 8.5 and incubated overnight with 
primary antibodies anti-BrdU (1:500; Fitzgerald) and anti-
S-100 (1:100; Immunostar). After washes, the cells were 
incubated for 2 hours with biotinylated IgG (1:200; Life 
Bioscience) and incubated overnight with Alexa 594 and 
Streptavidin 488 conjugated secondary antibodies (1:200; 
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Life Bioscience) and mounted with Mowiol (Sigma) con-
taining DAPI. To label MSCs, we used CD90 conjugated 
with FITC (1:100; BD Pharmingen).
Preparation of Cellular Constructs
For the preparation of the ECM, a volume of 800 μl 
of rat tail Type I collagen solution (BD Bioscience) at a 
concentration of 3 mg/ml was mixed with 100 μl of 10× 
Eagle’s medium (Gibco) and 4 μl of 7.5% sodium bicar-
bonate solution. These matrices were enriched with 200 
μl (20% final volume) of fibronectin (BD Biosciences) or 
laminin Type I (Sigma) at 1 mg/ml and kept in ice.
For the preparation of the cellular constructs, MSCs 
and SCs obtained from the cultures were resuspended in 
1 ml of medium. Cells were counted using a Neubauer 
chamber. Then, appropriate volumes of medium contain-
ing cells were centrifuged to get 750,000 cells. The pellet 
was resuspended in 1 ml of each of the matrices prepared.
MSCs and SCs were aligned within tethered collagen-
based gels enriched with either fibronectin or laminin in 
rectangular plastic ABS molds according to the method de-
scribed previously.18,32 The gels were integrated with a teth-
ering mesh of nylon at opposite ends. Tethered gels were 
immersed in culture medium and incubated at 37°C in a 
humidified incubator (5% CO2) overnight to allow align-
ment to develop. Control acellular matrices were subjected 
to the same procedure. The resulting constructs were sepa-
rated from the nylon mesh and placed on absorbent pads 
to stabilize. Then they were rolled and placed in chitosan 
tubes (19 mm long) that had been longitudinally cut.
Experimental Design and Surgical Procedure
For the in vivo experiments, 36 adult female Wistar 
Hannover rats (10 weeks old; 220–250 g) were used. Sur-
geries were performed under ketamine/xylazine anesthe-
sia (90/10 mg/kg administered intraperitoneally).
Right sciatic nerves were exposed and cut 96 mm from 
the third toe, and a nerve segment of 6 mm was resected. 
Nerve stumps were fixed to 19-mm-long chitosan tubes (2-
mm internal diameter) with 10-0 sutures, leaving a 15-mm 
gap. The wound was disinfected and the muscle plane and 
skin were sutured with absorbable silk sutures. The oper-
ated rats were given amitriptyline to prevent autotomy.30
Animals were distributed into 6 experimental groups, 
depending on the intraluminal contents of the tube: 
aligned collagen-fibronectin 20% and 750,000 MSCs (n 
= 6, FN-MSC group), aligned collagen-fibronectin 20% 
and 750,000 SCs (n = 7, FN-SC group), aligned collagen-
laminin 20% and 750,000 MSCs (n = 7, LM-MSC group), 
and aligned collagen-laminin 20% and 750,000 SCs (n 
= 8, LM-SC group); stabilized and rolled FN enriched 
construct (n = 4, FN-St) and stabilized and rolled LM-en-
riched constructs (n = 4, LM-St group) served as controls.
Once the animals were operated on, they received an 
injection of the immunosuppressant FK506 (Fujisawa 
Pharmaceuticals) at 2 mg/kg, and then daily subcutaneous 
injection of 1 mg/kg for up to 2 months. To prevent pos-
sible infections, all of the rats were treated with 500 mg/L 
amoxicillin (Normon) in their drinking water during the 
entire postoperative period.
Electrophysiological Tests
Electrophysiological tests were performed to evalu-
ate reinnervation of the target muscles monthly up to 120 
days postoperation (dpo). Animals were anesthetized and 
placed on a warm plate. The sciatic nerve was stimulated 
percutaneously by electrodes placed at the sciatic notch. 
The compound muscle action potential (CMAP) of the 
tibialis anterior, gastrocnemius, and plantar interosseus 
muscles was recorded.3 The amplitude and the latency of 
the M-wave were measured.
Functional Evaluation of Sensory Recovery
Mechanical (von Frey algesimeter from Bioseb) and 
thermal (plantar algesimeter from Ugo Basile) nociceptive 
responses were evaluated monthly up to 122 dpo. For both 
tests, the lateral area of the hind paw of the rats was stim-
ulated and compared with the contralateral paw used as 
control. The saphenous nerve was resected at 122 dpo to 
avoid confounding responses due to collateral reinnerva-
tion of this nerve from medial to lateral areas of the hind 
paw.9 Cutoff values were set at 40 g force for the von Frey 
and 20 seconds for the plantar test. Threshold responses 
were calculated as the mean of 3 measurements and ex-
pressed as percentage of response in the injured paw with 
respect to the contralateral intact paw of each animal.
Histology and Morphometry
At the end of the observation period (122 dpo), the 
animals were killed and perfused with 4% paraformalde-
hyde in PBS (0.1 M, pH 7.4) and postfixed in 3% para-
formaldehyde–3% glutaraldehyde in PBS. The nerves 
were postfixed in osmium tetroxide (2%, 2 hours, 4°C), 
dehydrated through ethanol series, and embedded in Epon 
resin. Semithin sections of the nerves (0.5 μm) were ob-
tained using an ultramicrotome (Leica) and stained with 
toluidine blue. Representative images of the whole regen-
erated nerve were acquired at 10×, and at least 30% of the 
nerve cross-sectional area was acquired at 100× to allow 
for counting of the number of myelinated fibers at midsec-
tion and distal part of the tube by means of ImageJ soft-
ware (National Institutes of Health).
Statistical Analysis
Results are expressed as mean ± standard error of the 
mean (SEM). Statistical comparisons between groups for 
MTT assay were made using a 1-way ANOVA followed 
by a Bonferroni post hoc test. Statistical comparisons be-
tween groups and intervals for algesimetry and electro-
physiological test results were made using a 2-way ANO-
VA followed by a Bonferroni test. Statistical comparisons 
between groups for histological results were made using 
nonparametric Kruskal-Wallis and Mann-Whitney U-
tests. Differences were considered significant if the p val-
ue was less than 0.05.
Results
Response of SCs and MSCs Cultured on Different ECM 
Components
Cell survival on different ECM coatings was examined 
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after 72 hours in culture (Fig. 1A) by using the MTT as-
say, which measures mitochondrial activity. We observed 
a significant increase of mitochondrial activity in SCs 
grown on laminin (19.89% ± 0.45%, p < 0.0001) or fibro-
nectin (8.57% ± 2.4%, p < 0.0001) compared with the ones 
grown on the control condition (poly-d-lysine) (Fig. 1B). 
The mitochondrial activity of SCs on laminin was also 
significantly higher than on fibronectin. When analyzing 
mitochondrial activity of MSCs, we found a significant 
increase on fibronectin (21.76% ± 0.54%, p < 0.0001) but 
not on laminin (10.76% ± 0.92%, p > 0.05) compared with 
poly-d-lysine (Fig. 1B).
We evaluated cell proliferation on the different coat-
ings by BrdU staining. After 72 hours in culture, we ob-
served similar proportions of BrdU-labeled (for both SCs 
or MSCs) on laminin and fibronectin compared with poly-
d-lysine (Fig. 1C).
Functional Reinnervation After In Vivo Implantation
Motor Reinnervation
Nerve conduction tests performed 1 week and 1 month 
after sciatic nerve injury demonstrated complete dener-
vation of the hindlimb muscles. Initial evidence of rein-
nervation of tibialis anterior and gastrocnemius muscles 
was found at 60 dpo in some animals of each group, with 
CMAPs of small amplitude. The CMAPs progressively 
increased in amplitude and were recorded in most animals 
over time, with a similar pattern for both muscles (Fig. 
2A and B). During the last electrophysiological test (120 
dpo), reinnervation of the tibialis anterior and gastrocne-
mius muscles was observed in 3 of 4 animals in the FN-St 
group, 3 of 4 in the LM-St group, 5 of 6 in the FN-MSC 
group, 6 of 7 in the LM-MSC group, 7 of 7 in the FN-SC 
group, and 8 of 8 in the LM-SC group. Significant differ-
ences for the tibialis anterior CMAP (p < 0.0001) were ob-
served at the final time point between FN-SC and LM-SC 
groups versus the groups of animals that received acellu-
lar constructs (FN-St and LM-St). Significant differences 
(p < 0.05) were also observed for the FN-SC and LM-SC 
groups versus the MSC construct (FN-MSC and LM-
MSC) groups (Fig. 2). At the final time point, significant 
differences in the gastrocnemius muscle (p < 0.05) were 
only observed between the FN-SC and the LM-St groups. 
Latencies of CMAPs were considerably longer than nor-
mal during the first stages of reinnervation and tended to 
shorten with time toward normal values. At the end of 
the postoperative observation period, the latencies of the 
CMAP recorded on tibialis anterior and gastrocnemius 
muscles were similar between groups (Fig. 2D and E).
Onset of reinnervation of the more distal plantar inter-
osseous muscles was detected at 60 dpo. In these cases, 
CMAPs were of very small amplitude (< 0.5 mV). At 120 
dpo, plantar CMAPs were recorded in 3 of 4 animals in 
the FN-St group, 3 of 4 in the LM-St group, 5 of 6 in the 
FN-MSC group, 6 of 7 in the LM-MSC group, 7 of 7 in the 
FN-SC group, and 8 of 8 in the LM-SC group. Significant 
differences (p < 0.0001) were observed between the FN-
SC group and the rest of the groups (Fig. 2). The plantar 
CMAP latency followed a similar pattern to that described 
for the proximal muscles, returning toward normal values 
during the regeneration process, without significant differ-
ences between groups. Results are summarized in Table 1.
Sensory Reinnervation
Withdrawal responses to mechanical and thermal stim-
uli were evaluated by means of the von Frey test and the 
plantar test, respectively. Values are presented as percent-
age of response of the injured versus the contralateral in-
tact paw (to overcome possible variations between testing 
conditions) of each individual at each time point. Either 
mechanical or heat nociceptive thresholds were taken as 
the mean of 3 measurements per paw region per animal; 
values were grouped per individual animal and compared 
to the mean of the 3 measurements obtained for the con-
tralateral intact paw of that animal. Absence of responses 
at the lateral part of the paw on the repaired side of the rats 
during the first 30 dpo demonstrated complete denerva-
tion. When animals did not respond to either mechanical 
or heat stimuli, these were penalized with cutoff values 
(40 g and 20 seconds, respectively).
Withdrawal responses to mechanical stimuli from 60 
to 120 dpo showed that the paw on the repaired side re-
sponded to lower intensity stimulus compared with the 
contralateral paw, indicating some degree of hyperalgesia 
(Fig. 3A). After elimination of the saphenous nerve at 120 
dpo, the mechanical withdrawal responses in the different 
groups compared with their contralateral side at 122 dpo 
were 74 ± 21 g in FN-St group, 63 ± 15 g in LM-St group, 
70 ± 17 g in FN-MSC group, 67 ± 15 g in the LM-MSC 
group, 68 ± 14 g in the FN-SC group, and 53 ± 3 g in 
the LM-SC group, without significant differences between 
groups.
Similarly, withdrawal responses to heat stimuli in the 
plantar test showed no response on the denervated paw 
during the first 30 dpo. From 60 to 120 dpo, most rats 
showed withdrawal responses at lower stimulus intensity 
than in the contralateral paw (Fig. 3B). After cutting the 
saphenous nerve, the withdrawal time of the injured paw 
at 122 dpo increased to average values of 134 ± 60 seconds 
in the FN-St group, 124 ± 11 seconds in the LM-St group, 
134 ± 58 seconds in the FN-MSC group, 117 ± 17 sec-
onds in the LM-MSC group, 95 ± 6 seconds in the FN-SC 
group, and 134 ± 25 seconds in the LM-SC group, without 
significant differences between groups.
Histological Results
Macroscopic examination of regenerated nerves after 4 
months postinjury revealed that 3 of 4 animals in the FN-
St and LM-St groups, 5 of 6 animals in the FN-MSC, 6 of 
7 animals in the LM-MSC, 7 of 7 animals in the FN-SC, 
and 8 of 8 animals in the LM-SC presented a regenerated 
cable inside the chitosan tube (Fig. 4 and Fig. 5G). The re-
paired nerves were surrounded by a thick connective layer. 
Transverse sections of the regenerated nerves taken at the 
midpoint of the tube and 3 mm distal to the distal suture 
were analyzed under light microscopy (Fig. 5A and B). 
To compare the number of myelinated fibers, all rats were 
included in the statistical analysis, giving null values to 
nonregenerated animals. The mean number of myelinated 
fibers at the midpoint of the tube was higher in the FN-SC 
group (7656 ± 1379) followed by the LM-SC group (6677 
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FIG. 1. A: Representative images of cultured SCs (upper) and MSCs (lower) on poly-d-lysine, laminin, and fibronectin coatings. 
Scale bar = 50 µm. B: Results of the MTT assay of dissociated SCs and MSCs cultured for 72 hours, presented as percentage 
of mitochondrial activity of the cells on laminin- or fibronectin-coated surfaces vs poly-d-lysine–treated wells. ***p < 0.0001. C: In 
vitro proliferation of SCs (upper) and MSCs (lower) grown on poly-d-lysine–, laminin-, and fibronectin-coated surfaces after 72 
hours in culture. BrdU was incorporated in the media after 48 hours in culture and cells were fixed after 24 hours. Cultures were 
labeled for BrdU (red), DAPI (blue), and S-100 for SCs (green, upper) or CD90 for MSCs (green, lower). For group definitions, 
please refer to the Experimental Design and Surgical Procedure subsection of Methods. Scale bar = 100 µm. Figure is available in 
color online only.
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± 1119), the FN-MSC group (6192 ± 1999), the LM-MSC 
group (5750 ± 2198), the LM-St group (3458 ± 1795), and 
the FN-St group (3105 ± 1348) (Fig. 5C). The same pat-
tern was observed in the distal nerve, where the number 
of myelinated fibers was higher in the FN-SC group (4771 
± 683), followed by the LM-SC group (3927 ± 524), the 
FN-MSC group (3228 ± 907), the LM-MSC group (3076 ± 
962), the FN-St group (2915 ± 837), and the LM-St group 
FIG. 2. A–C: Mean amplitude of the compound muscle action potential (CMAP) of tibialis anterior (A), gastrocnemius (B), and 
plantar muscles (C) of the injured limb. +p < 0.05 and +++p < 0.0001 between FN-SC and LM-St groups; @@@p < 0.0001 between 
LM-SC and LM-St groups; $$$p < 0.0001 between FN-SC and FN-St groups; &&p < 0.001 between LM-SC and FN-St groups; %%p < 
0.001 between LM-SC and LM-MSC groups; !p < 0.05 between LM-SC and FN-MSC groups; ^^^p < 0.0001 between FN-SC and 
LM-MSC groups; *p < 0.05 and ***p < 0.001 between FN-SC and FN-MSC groups; and ???p < 0.001 between FN-SC and LM-SC 
groups. D–F: Mean values of the CMAP latency for the same muscles. Error bars represent SEM. Figure is available in color 
online only.
TABLE 1. Summary of data obtained in the present study and collected data from historical results in the 15-mm-
autograft group from our laboratory in past studies
Group
% of Rats w/  
Regeneration
% Recovery No. of Myelinated Fibers
TA CMAP GM CMAP PL CMAP Von Frey Test Plantar Test At Midlevel At Distal Level
AG 100 60 60 33 61 128 14,409 6,865
LM-St 75 23 30 15 63 124 3,458 2,079
FN-St 75 23 35 23 74 137 3,105 2,915
LM-SC 100 41 51 24 60 134 6,677 3,927
FN-SC 100 43 54 49 68 94 7,656 4,771
LM-MSC 86 27 42 20 67 117 5,750 3,076
FN-MSC 83 32 34 23 69 134 6,192 3,228
AG = autograft; GM = gastrocnemius; PL = plantar interosseous; TA = tibialis anterior. 
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(2079 ± 711) (Fig. 5D), but differences were only signifi-
cant between the FN-SC group and LM-St and FN-St 
groups at the distal level.
The area of the regenerated nerves at the midlevel and 
the distal level did not show significant differences be-
tween groups (Fig. 5E and F). The highest values were 
found for both mid-tube and distal nerve levels in the FN-
SC group (0.33 ± 0.08 μm2 and 0.30 ± 0.05 μm2), followed 
by the LM-SC group (0.31 ± 0.10 μm2 and 0.28 ± 0.03 
μm2), the FN-MSC group (0.28 ± 0.10 μm2 and 0.26 ± 0.10 
μm2), the LM-MSC group (0.28 ± 0.16 μm2 and 0.25 ± 0.18 
μm2), the FN-St group (0.26 ± 0.10 μm2 and 0.14 ± 0.10 
μm2), and the LM-St group (0.24 ± 0.07 μm2 and 0.12 ± 
0.05 μm2). Again, differences were found significant only 
for the FN-SC group and LM-St and FN-St groups at the 
distal level.
Discussion
In this study we have compared the effect of aligned 
constructs of SCs or MSCs in a collagen Type I–based 
matrix enriched with either fibronectin or laminin. These 
constructs were tested in chitosan conduits for their abil-
ity to promote axonal regeneration across a critical 15-mm 
gap of the sciatic nerve in rats. Our results show that in-
clusion of aligned SCs in either fibronectin- or laminin-
enriched scaffolds was associated with regeneration of 
peripheral nerves in 100% of cases and provided the best 
levels of regeneration and functional recovery, compared 
with MSC-containing constructs and acellular scaffolds.
The use of artificial nerve guides has been proposed 
to replace the autograft in the repair of severe peripheral 
nerve lesions. Development of artificial nerve guides has 
progressed during the last decades to yield a variety of bio-
degradable and biocompatible devices.10 In this study, we 
used a chitosan tube that has already been demonstrated 
to be more effective than the standard silicone tube for 
supporting axonal regeneration across limiting gaps in 
rats.16,17,20 However, the percentage of success after repair 
with a hollow chitosan tube was still far from the 100% 
of regenerated cases reached when using an autograft 
to bridge such a long nerve gap. Regeneration in hollow 
conduits is highly dependent on the formation of an ini-
tial fibrin cable, which serves as a guidance structure for 
fibroblasts, SCs, and blood vessels to migrate and popu-
late the cable and facilitate axonal regeneration. To further 
mimic the natural geometry and architecture of the endo-
neurium in nerve grafts, cellular and extracellular compo-
nents should be longitudinally aligned. Among different 
techniques (gradients, electrical fields, magnetic fields, 
nanofibers, etc.), cells embedded in tethered ECM-based 
hydrogels can self-align in response to cell-generated ten-
sion to form tracts of engineered neural tissue.15,33
Immunosuppression with FK506 for the first 2 months 
after the operation was used to avoid rejection of alloge-
neic transplanted cells. Since administration of FK506 has 
been demonstrated to enhance regeneration and functional 
recovery after peripheral nerve injuries,37 groups with 
acellular constructs were also treated with the drug. In 
these groups, the percentage of animals with a regenerat-
ing cable in the tube was about 75%, similar to the results 
obtained in a previous study in which animals were not 
treated with FK506 (data not published). In contrast, inclu-
sion of aligned cells increased the success of axonal regen-
eration up to 100%.
Both SCs and MSCs have been used to promote nerve 
FIG. 3. Mechanical (A) and thermal (B) algesimetry test results. Values are the group mean of the percentage of withdrawal re-
sponse to the noxious stimuli applied to the lateral side of the paw on the injured side versus the intact side. The horizontal dotted 
lines represent the normalized baseline values. The vertical dotted lines indicate when the saphenous nerve was cut, at 120 dpo; 
then the rats were tested again at 122 dpo. Error bars represent SEM. Figure is available in color online only.
FIG. 4. Representative images of regenerated nerves 4 months after 
repair using constructs enriched with fibronectin or laminin and contain-
ing either aligned SCs, MSCs, or no cells (acellular). The chitosan tubes 
have been removed to aid visualization. Black arrows indicate the gap 
bridged with the formed regenerated cable. The values on the ruler be-
low the nerves are in millimeters. Figure is available in color online only.
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FIG. 5. A and B: Representative images of semithin sections of the regenerated nerves taken at the midpoint of the tube (A) and 
distal to the tube (B) 4 months after sciatic nerve resection and repair, from a representative animal of each group. Scale bar = 
10 µm. C and D: Estimated number of regenerated myelinated fibers in the tibial nerve at the mid-tube (C) and 3 mm distal to the 
tube (D) 4 months after sciatic nerve resection and repair. *p < 0.05 vs Lm St and FN St groups. E and F: Cross-sectional area 
of the regenerated nerve at mid-tube (E) and 3-mm-distal (F) levels. Animals with no regenerated nerve were also included (with 
null values) in the calculations. Error bars represent SEM. G: The percentage of animals that presented a regenerated nerve at 
120 dpo in the different experimental groups. Figure is available in color online only.
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regeneration and provide support in long peripheral nerve 
gaps. The potential ability of those cells relies mainly on 
populating the neural guide and continuously producing 
neurotrophic factors.26 Interestingly, SC-aligned hydrogels 
allowed regeneration in a slightly higher proportion of ani-
mals than MSC-aligned constructs. These differences may 
be determined by the different behavior of these cell types 
in the scaffolds. ECM molecules like laminin or fibronec-
tin influence cell and tissue behavior by providing an adhe-
sive substrate to anchorage-dependent cells and determine 
a variety of cell differentiation processes.13 For instance, 
Abdeen and colleagues1 demonstrated a positive correla-
tion between fibronectin, stiffness, and proangiogenic sig-
naling of MSCs in 2D hydrogels. Indeed, in another study, 
the angiogenic marker PECAM was decreased in MSCs 
when cultured on laminin matrices.13 On the other hand, SC 
proliferation increased in laminin2 and fibronectin5 in vitro. 
In this study we also tested the performance of MSCs and 
SCs on laminin- and fibronectin-coated surfaces in vitro 
and found that MSCs survived better on fibronectin-coated 
surfaces and SCs on laminin-coated surfaces. However, 
in vivo SCs seeded in fibronectin-aligned matrices pro-
vided better functional results than SCs seeded in laminin-
aligned matrices. The positive effect of fibronectin on SC 
proliferation and migration has been previously proved.5,29 
On the other hand, independent of the ECM matrix used 
for the aligned constructs, functional recovery was better 
in SC groups than in MSC groups.
Overall, our results indicate that SCs are better candi-
dates than MSCs for populating neural conduits to pro-
mote nerve regeneration. This is not surprising, since SCs 
are the glial cells of the peripheral nervous system and 
thus responsible for guiding axons toward their target or-
gans. However, their clinical use is limited, since acquisi-
tion of autologous primary SCs requires the extraction of a 
donor nerve and the consequent loss of its function. More-
over, to amplify the number of cells obtained, a period of 
preoperative cultivation is needed,22 during which SCs 
lose their phenotypic characteristics in vitro24 and increase 
the proregenerative potency.35 Nevertheless, skin-derived 
stem cells have been reported as an accessible and autolo-
gous alternative source of SCs for therapeutic application 
to injured peripheral nerves. These skin precursor–de-
rived SCs have regenerative attributes that resemble those 
of acutely denervated SCs and, when grafted in injured 
nerves, they have demonstrated positive effects on nerve 
regeneration.23,36,40
In contrast, MSCs are easily harvested from bone mar-
row or several other tissues and exhibit great plasticity for 
differentiating toward multiple cell types,4 allowing for 
adjustment of the requirements needed to promote axo-
nal regeneration. Probably the predifferentiation of these 
cells toward SC-like cells, acquiring the capacity of guid-
ing and myelinating peripheral axons,11,31 will improve 
their regenerative capacity when used to enrich artificial 
conduits to repair long nerve gaps. Although some stud-
ies have indicated that MSCs have positive effects when 
directly transplanted into injured nerves28 or used to seed 
nerve grafts,22,39 SCs are still the key element to consis-
tently sustain nerve regeneration through limiting nerve 
gaps.
Conclusions
The combination of cell therapy and tissue engineer-
ing resulted in marked improvement in the success of re-
generation and the degree of functional recovery achieved 
after repairing a critical nerve gap with a chitosan guide, 
providing support for tube repair as a potential alternative 
to autograft in the repair of injured peripheral nerves. SC-
seeded grafts are likely the best alternative to the autograft 
for repairing long-gap peripheral nerve injuries, since they 
allowed successful regeneration in all the animals includ-
ed in the study and provided the highest values of regen-
eration reported with artificial nerve grafts.
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